MoneyWorks4Me

GlaxoSmithKline Pharmaceuticals board to consider unaudited financial results

08 Apr 2014 Evaluate

GlaxoSmithKline Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on April 17, 2014, to consider approval of unaudited financial results for the quarter ended March 31, 2014 (Q1).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..